Motivators to participation in medical trials: The application of social and personal categorization

References

• Altschuler, A., & Somkin, C.P. (2005). Women’s decision making about whether or not to use breast cancer chemoprevention. Women & Health, 41(2), 81–95.
   PubMed Web of Science ®Google Scholar
• Austenfeld, J.L., & Stanton, A.L. (2004). Coping through emotional approach: A new look at emotion, coping, and health-related outcomes. Journal of Personality, 72(6), 1335–1363.
   PubMed Web of Science ®Google Scholar
• Bakari, M., Aboud, S., Nilsson, C., Francis, J., Buma, D., Moshiro, C., & Sandström, E. (2011). Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania. Vaccine, 29(46), 8417–8428.
   PubMed Web of Science ®Google Scholar
• Balfour, L., Corace, K., Tasca, G.A., Tremblay, C., Routy, J.P., & Angel, J.B. (2010). Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173). AIDS Care, 22(11), 1403–1409.
   PubMed Web of Science ®Google Scholar
• Belshe, R.B., Stevens, C., Gorse, G.J., Buchbinder, S., Weinhold, K., Sheppard, H., & Woody, G. (2001). Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers. Journal of Infectious Diseases, 183(9), 1343–1352.
   PubMed Web of Science ®Google Scholar
• Buchbinder, S.P., Metch, B., Holte, S.E., Scheer, S., Coletti, A., & Vittinghoff, E. (2004). Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes, 36(1), 604–612.
   PubMed Web of Science ®Google Scholar
• Chesney, M.A., Chambers, D.B., & Kahn, J.O. (1997). Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16(4), 266–271.
   PubMedGoogle Scholar
• Cleghorn, F., Pape, J.W., Schechter, M., Bartholomew, C., Sanchez, J., Jack, N., & Wright, P.F. (2007). Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120. Journal of Acquired Immune Deficiency Syndromes, 46(2), 222–230.
   PubMed Web of Science ®Google Scholar
• Colfax, G., Buchbinder, S., Vamshidar, G., Celum, C., McKirnan, D., Neidig, J., & Bartholow, B. (2005). Motivations for participating in an HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes, 39(3), 359–364.
   PubMed Web of Science ®Google Scholar
• Cox, K., & McGarry, J. (2003). Why patients don’t take part in cancer clinical trials: An overview of the literature. European Journal of Cancer Care, 12(2), 114–122.
   PubMed Web of Science ®Google Scholar
• Coyne, J.C., & Racioppo, M.W. (2000). Never the twain shall meet? Closing the gap between coping research and clinical intervention research. The American Psychologist, 55(6), 655–664.
   PubMed Web of Science ®Google Scholar
• Crumbo, C.L., Rybczyk, G.K., & Wagner, L.J. (1997). Characteristics of volunteer participants in phase I HIV vaccine trials. Journal of the Association of Nurses in AIDS Care, 8(5), 59–65.
   PubMedGoogle Scholar
• Dhalla, S., & Poole, G. (2011). Motivators of enrolment in HIV vaccine trials: A review of HIV vaccine preparedness studies. AIDS Care, 23(11), 1430–1447.
   PubMed Web of Science ®Google Scholar
• Ellis, P.M. (2000). Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature. Annals of Oncology, 11(8), 939–945.
   PubMed Web of Science ®Google Scholar
• Fayter, D., McDaid, C., & Eastwood, A. (2007). A systematic review highlights threats to validity in studies of barriers to cancer trial participation. Journal of Clinical Epidemiology, 60(10), 990–1001.
   PubMed Web of Science ®Google Scholar
• Frese, M., & Zapf, D. (1994). Action as the core of work psychology: A German approach. In: H. C. Triandis, M. D. Dunnette & L. M. Hough (Eds.), Handbook of industrial and organizational psychology (pp. 271–340). Palo Alto, CA: Consulting Psychologists Press.
   Google Scholar
• Gray, K., Legg, K., Sharp, A., Mackie, N., Olarinde, F., De Souza, C., & Peters, B. (2008). Participation in two phase II prophylactic HIV vaccine trials in the UK. Vaccine, 26(23), 2919–2924.
   PubMed Web of Science ®Google Scholar
• Hagerty, R.G., Butow, P.N., Ellis, P.M., Lobb, E.A., Pendlebury, S.C., Leighl, N., & Tattersall, M.H. (2005). Communicating with realism and hope: Incurable cancer patients’ views on the disclosure of prognosis. Journal of Clinical Oncology, 23(6), 1278–1288.
   PubMed Web of Science ®Google Scholar
• Harro, C.D., Judson, F.N., Gorse, G.J., Mayer, K.H., Kostman, J.R., Brown, S.J., & Popovic, V. (2004). Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes, 37(3), 1385–1392.
   PubMed Web of Science ®Google Scholar
• Jenkins, R.A., Chinaworapong, S., Morgan, P.A., Ruangyuttikarn, C., Sontirat, A., Chiu, J., & Khamboonruang, C. (1998). Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(2), 171–177.
   PubMedGoogle Scholar
• Jenkins, R.A., Thapinta, D., Morgan, P.A., Wongkamhaeng, S., Sornsathapornkul, P., Bussaratid, V., & Brown, A.E. (2005). Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand. Journal of Acquired Immune Deficiency Syndromes, 40(5), 592–599.
   PubMed Web of Science ®Google Scholar
• Johnson, M.O. (1999). Belief of vaccine receipt in HIV vaccine trials: Further cautions. Journal of Acquired Immune Deficiency Syndromes, 21(5), 413–416.
   PubMed Web of Science ®Google Scholar
• Kahn, J.O., Cherng, D.W., Mayer, K., Murray, H., & Lagakos, S. (2000). Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 × 10(6)/L CD4 cell counts: A randomized controlled trial. Journal of the American Medical Association, 284(17), 2193–2202.
   PubMed Web of Science ®Google Scholar
• Lucero, M.C., Diaz-Brito, V., Murillo, B.T., Carretero, S.C., Sala, M., Casadesus, C., & Garcia, F. (2012). Reasons for not participating in a phase 1 preventive HIV vaccine study in a resource-rich country. AIDS Patient Care and STDs, 26(7), 379–382.
   PubMed Web of Science ®Google Scholar
• Luschin, G., Habersack, M., & Gerlich, I.A. (2012). Reasons for and against participation in studies of medicinal therapies for women with breast cancer: A debate. BMC Medical Research Methodology, 12, 25.
   PubMed Web of Science ®Google Scholar
• Luzi, A.M., Gallo, P., Colucci, A., Marcotullio, S., Bellino, S., Longo, O., & Ensoli, B. (2011). Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/AIDS based on the recombinant HIV-1 tat protein. AIDS Care, 23(8), 939–946.
   PubMed Web of Science ®Google Scholar
• McClure, C.A., Gray, G., Rybczyk, G.K., & Wright, P.F. (2004). Challenges to conducting HIV preventative vaccine trials with adolescents. Journal of Acquired Immune Deficiency Syndromes, 36(2), 726–733.
   PubMed Web of Science ®Google Scholar
• McMahon, V.A., Matthews, S., Capper, H., Chudleigh, J.B., & McLachlan, C.S. (2011). Understanding decision and enabling factors influencing clinical trial participation in Australia: A view point. Asian Pacific Journal of Cancer Prevention, 12(11), 3153–3156.
   PubMed Web of Science ®Google Scholar
• Mills, E., Nixon, S., Singh, S., Dolma, S., Nayyar, A., & Kapoor, S. (2006). Enrolling women into HIV preventive vaccine trials: An ethical imperative but a logistical challenge. PLoS Medicine, 3(3), e94.
   PubMed Web of Science ®Google Scholar
• Moodley, K. (2002). HIV vaccine trial participation in South Africa – an ethical assessment. Journal of Medical Philosophy, 27(2), 197–215.
   PubMed Web of Science ®Google Scholar
• Moodley, K., Barnes, J., van Rensburg, E.J., & Myer, L. (2002). Willingness to participate in South African HIV vaccine trials – concerns of medical professionals in the Western Cape. South African Medical Journal, 92(11), 904–906.
   PubMed Web of Science ®Google Scholar
• Moore, S. (2001). A need to try everything: Patient participation in phase I trials. Journal of Advanced Nursing, 33(6), 738–747.
   PubMed Web of Science ®Google Scholar
• Newman, P.A., Daley, A., Halpenny, R., & Loutfy, M. (2008). Community heroes or “high-risk” pariahs? Reasons for declining to enroll in an HIV vaccine trial. Vaccine, 26(8), 1091–1097.
   PubMed Web of Science ®Google Scholar
• Padilla, G.V., Ferrell, B., Grant, M.M., & Rhiner, M. (1990). Defining the content domain of quality of life for cancer patients with pain. Cancer Nursing, 13(2), 108–115.
   PubMed Web of Science ®Google Scholar
• Phanuphak, P., Teeratakulpixarn, S., Sarangbin, S., Nookhai, S., Ubolyam, S., Sirivichayakul, S., & Koff, W.C. (1997). International clinical trials of HIV vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand. Asian Pacific Journal of Allergy and Immunology, 15(1), 41–48.
   PubMed Web of Science ®Google Scholar
• Pitisuttithum, P., Choopanya, K., & Rerk-Ngnam, S. (2010). HIV-vaccine research and development in Thailand: Evolution and challenges. Vaccine, 28(Suppl. 2), B45–B49.
   PubMed Web of Science ®Google Scholar
• Tarimo, E.A., Thorson, A., Kohi, T.W., Bakari, M., Sandstrom, E., Mhalu, F., & Kulane, A. (2011). A qualitative evaluation of volunteers’ experiences in a phase I/II HIV vaccine trial in Tanzania. BMC Infectious Diseases, 11, 283.
   PubMed Web of Science ®Google Scholar
• Thapinta, D., Jenkins, R.A., Morgan, P.A., Chiu, J., Boenim, W., Bussaratid, V., & Thongchareon, P. (2002). Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand. Journal of Acquired Immune Deficiency Syndromes, 30(5), 503–513.
   PubMed Web of Science ®Google Scholar
• Todd, A.M., Laird, B.J., Boyle, D., Boyd, A.C., Colvin, L.A., & Fallon, M.T. (2009). A systematic review examining the literature on attitudes of patients with advanced cancer toward research. Journal of Pain and Symptom Management, 37(6), 1078–1085.
   PubMed Web of Science ®Google Scholar
• Tournoux, C., Katsahian, S., Chevret, S., & Levy, V. (2006). Factors influencing inclusion of patients with malignancies in clinical trials. Cancer, 106(2), 258–270.
   PubMed Web of Science ®Google Scholar
• Vanichseni, S., Tappero, J.W., Pitisuttithum, P., Kitayaporn, D., Mastro, T.D., Vimutisunthorn, E., & Choopanya, K. (2004). Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand. AIDS, 18(2), 311–316.
   PubMed Web of Science ®Google Scholar
• Verheggen, F.W., Nieman, F., & Jonkers, R. (1998). Determinants of patient participation in clinical studies requiring informed consent: Why patients enter a clinical trial. Patient Education and Counseling, 35(2), 111–125.
   PubMed Web of Science ®Google Scholar
• Voytek, C.D., Jones, K.T., & Metzger, D.S. (2011). Selectively willing and conditionally able: HIV vaccine trial participation among women at “high risk” of HIV infection. Vaccine, 29(36), 6130–6135.
   PubMed Web of Science ®Google Scholar
• White, C., & Hardy, J. (2010). What do palliative care patients and their relatives think about research in palliative care?-a systematic review. Support Care Cancer, 18(8), 905–911.
   PubMed Web of Science ®Google Scholar